Views & Analysis
Peter Barschdorff

Harnessing data and insights for success

Ahead of the eyeforpharma Awards shortlist announcement this week, we spoke to judge and commercial insights executive Peter Barschdorff about how data and insights are changing pharma

News
BenevolentAI_Babraham

BenevolentAI and Novartis sign AI R&D deal

The Artificial Intelligence (AI)-based drug development firm BenevolentAI has signed an agreement with Novartis to find potential new uses for oncology drugs already in its pipeline.

Debates

News

Press Releases

Newsletters and Deep Dive
digital magazine

Views & Analysis

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content